Dose of vitamin D in children with chronic kidney disease
Phase 1
Completed
- Conditions
- Health Condition 1: null- Chronic Kidney diseaseHealth Condition 2: N183- Chronic kidney disease, stage 3 (moderate)
- Registration Number
- CTRI/2017/11/010385
- Lead Sponsor
- St Johns Medical College Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 90
Inclusion Criteria
Chronic kidney disease stages 2 to 4 (eGFR 15-90 ml/min/1.73m2) with vitamin D level <30ng/ml
Exclusion Criteria
those children who have received vitamin D supplements in the last 3 months
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum levels of vitamin D 30ng/ml at completion of therapy at 3 monthsTimepoint: Serum levels of vitamin D 30ng/ml at completion of therapy at 3 months
- Secondary Outcome Measures
Name Time Method To maintain the normal vitamin D level (30ng/ml) with maintenance therapyTimepoint: at 6, 9 and 12 months